U.S. Tech Hardware Stock News

Recent performance snapshot General Dynamics (GD) is on the radar for many investors after its recent share price moves, with the stock showing a mix of small daily gains and short term pullbacks alongside stronger longer term returns. See our latest analysis for General Dynamics. At a share price of US$355.23, General Dynamics has seen momentum cool slightly in recent weeks, with a 30 day share price return of a 1% decline. However, the 1 year total shareholder return of 38.64% and 5 year...

AMD (NasdaqGS:AMD) CEO Lisa Su is planning a trip to South Korea for direct talks with Samsung Electronics and Naver on high bandwidth memory supplies and data center partnerships. The company has also taken a founding role in the new Optical Compute Interconnect MSA, aimed at setting standards for future AI infrastructure. For investors watching the AI hardware race, this points to where AMD is putting its energy right now. Securing high bandwidth memory is central for AI accelerators, and...

In March 2026, Legend Biotech reported fourth-quarter 2025 revenue of US$306.3 million, up from US$186.5 million a year earlier, with an adjusted profit of US$0.01 per share but a GAAP net loss of US$30.9 million for the quarter and US$296.8 million for the full year on revenue of US$1.03 billion. The company’s CARVYKTI franchise reached more than 10,000 treated patients, achieved product-level profitability in 2025, and expanded to 294 treatment sites across 14 markets while scaling...

HubSpot (NYSE:HUBS) has amended its by laws to require that U.S. federal courts serve as the exclusive forum for securities law complaints. This governance change affects how shareholders can bring securities related claims against the company and where those cases are heard. HubSpot builds customer relationship management and marketing software that is widely used by small and mid sized businesses looking to manage sales, marketing, and customer support in one place. As software and cloud...

Astrana Health (ASTH) has been drawing fresh attention after its recent rebrand from Apollo Medical Holdings, shifting its identity while continuing to focus on healthcare management and coordination across Medicare, Medicaid and commercially insured patients. See our latest analysis for Astrana Health. The recent rebrand comes against a mixed backdrop, with a 30 day share price return of 20.65% contrasting with a 1 year total shareholder return decline of 20.36%. This suggests shorter term...

Earlier in March 2026, Morningstar, Inc. introduced an AI assistant embedded in its Direct Advisory Suite, unifying investment research, portfolio analysis, and proposal generation in a single, context-aware workspace for financial advisors. This launch highlights Morningstar’s push to become an “intelligence layer” for investing, weaving its independent data and research directly into advisors’ day-to-day workflows while maintaining enterprise-grade security standards. We’ll now look at how...

BK Technologies (BKTI) just posted fourth quarter FY 2025 revenue of US$21.5 million with basic EPS of US$1.12, alongside trailing 12 month revenue of US$86.1 million and EPS of US$3.69 that reflect the broader run rate coming into this report. The company has seen revenue move from US$17.9 million in Q4 2024 to US$21.5 million in Q4 2025, with basic EPS shifting from US$1.03 to US$1.12 over the same period, setting up a picture of earnings that feed into trailing 12 month net income of...

If you are wondering whether Tutor Perini is still good value after its strong run, the key question now is how the current share price compares with what the business might be worth. The stock closed at US$69.20, with returns of 181.2% over the past year and a very large 3 year gain, so the recent 19.5% 30 day pullback and 2.7% 7 day decline may have some shareholders reassessing the balance between potential upside and risk. Recent news coverage has focused on Tutor Perini's position as a...

Magnolia Oil & Gas (NYSE:MGY) has reported significant growth in its proved developing producing reserves. The company also highlighted continued increases in production levels. This operational update focuses on changes in Magnolia's resource base and output profile, rather than on valuation or analyst forecasts. For investors tracking NYSE:MGY, this reserve and production update adds fresh operational context to a share price that most recently closed at $28.94. The stock has returned...

If you are wondering whether Mueller Water Products at about US$27.62 is offering fair value or a potential bargain, looking at how the stock is priced against its fundamentals can help you frame that question more clearly. The share price has eased in the short term, with a 4.5% decline over 7 days and a 6.2% decline over 30 days, while still sitting on a 15.4% gain year to date and a 6.1% return over the past year. These moves sit against a backdrop of ongoing interest in water...

If you are wondering whether Ameren's current share price lines up with its underlying value, you are not alone. This article is designed to help you frame that question clearly. Ameren's stock last closed at US$110.00, with returns of a 1.3% decline over 7 days, 4.0% over 30 days, 9.1% year to date, 15.5% over 1 year, 40.3% over 3 years and 62.1% over 5 years, which raises fair questions about what is already reflected in the price. Recent coverage around Ameren has focused on its role in...

Prairie Operating recently announced major leadership changes, including the past voluntary resignation of CEO and Chairman Edward Kovalik and the appointment of director Richard N. Frommer as Interim CEO and President, with Erik Thoresen becoming Chairman. The combination of an experienced interim leader with deep Rocky Mountain oil and gas credentials and an active search for permanent executives signals a potential shift in how Prairie Operating plans, finances, and communicates its next...

If you are wondering whether Icahn Enterprises is a bargain or a value trap at its recent price of US$7.59, you are not alone. The stock has seen a 7.7% gain over the past year, although the last 7 days and 30 days reflected declines of 7.7% and 7.1% respectively, with a 1.5% return year to date and longer term 3 and 5 year returns of 71.8% and 65.4% declines. Recent headlines around Icahn Enterprises have often focused on the broader performance of the Icahn investment vehicle and its...

Earlier this month, Deckers’ UGG and Teva divisions launched Spring 2026 collections, expanding into warm‑weather sandals, clogs, and performance outdoor footwear while highlighting recycled materials and technical innovations across their lines. These product expansions arrive alongside strong recent earnings beats and rising analyst optimism, suggesting that new offerings are increasingly central to Deckers’ evolving long-term story. We’ll now explore how Deckers’ broadened year-round...

Why Universal Health Services is on investors’ radar today Universal Health Services (UHS) has attracted attention after recent share price moves, with the stock up 2.3% in the latest session but showing weaker performance over the past month and past 3 months. That mixed return profile is set against a business generating US$17.4b in revenue and US$1.5b in net income, giving investors a sizable, established healthcare operator to evaluate beyond the near term price swings. See our latest...

Wondering whether Johnson & Johnson is fairly priced at its current level, or if the market is missing something in this healthcare giant's story? The stock recently closed at US$242.04, with returns of 1.0% over the last week, 1.5% over the last month, 16.7% year to date, 52.6% over 1 year, 71.8% over 3 years and 73.7% over 5 years. These figures may influence how you think about its current value. Recent headlines around Johnson & Johnson have focused on its position as a major global...

Tempus AI (TEM) is back in focus after publishing a JCO Precision Oncology study showing its advanced comprehensive genomic profiling tools identified actionable cancer treatment options that standard in network tests missed for about 12% of patients. See our latest analysis for Tempus AI. The study arrives after a busy few weeks, with Tempus AI striking an expanded multi year collaboration with Merck and a new alliance with NYU Langone Health. Yet the share price has seen a 29.85% 90 day...

What the recent move in H2O America means for investors H2O America (HTO) has quietly caught investor attention after its recent share price move, supported by positive 1-day, week, month, and past 3 months returns, prompting a closer look at its fundamentals. See our latest analysis for H2O America. With the share price at $57.36 and a 30-day share price return of 9.84% alongside a 90-day gain of 16.94%, short-term momentum looks stronger than the more modest 10.84% 1-year total shareholder...

Barclays has initiated coverage on Nova (NVMI) with a positive stance, highlighting the company’s role in metrology as chip manufacturing moves toward more measurement intensive processes and as wafer fab equipment spending increases. See our latest analysis for Nova. Novo’s share price has cooled recently, with a 1 day share price return of a 3.6% decline and a 30 day share price return of an 8.8% decline. Its 1 year total shareholder return of 95.2% and 3 year total shareholder return of...

If you are wondering whether Celsius Holdings is still priced attractively or already reflects a lot of optimism, the rest of this article is designed to help you make sense of the current valuation. The stock last closed at US$43.68, with returns of 0.0% over 7 days, a 5.8% decline over 30 days, an 8.5% decline year to date, and a 64.0% gain over the past year. Recent coverage has focused on Celsius Holdings as a fast growing name in the functional beverage space and on how investors are...

Sea (NYSE:SE) has drawn investor attention after recent share price pressure, with the stock showing declines over the past month and past 3 months. That backdrop puts more focus on its latest financial profile. See our latest analysis for Sea. Sea’s recent 1 month share price return of a 24.86% decline and year to date share price return of a 35.23% decline point to fading momentum, even though the 3 year total shareholder return of 8.8% is still positive. If this pullback has you looking...

If you are wondering whether Yelp's current share price lines up with its underlying business, this article will walk through what the numbers are really saying about its value. Yelp recently closed at US$24.05, with returns of a 0.9% decline over 7 days, 1.2% decline over 30 days, 20.4% decline year to date and 29.3% decline over 1 year. The 3 year and 5 year returns stand at 19.2% decline and 43.1% decline respectively. Recent attention on Yelp has been shaped by ongoing discussion around...

Blackstone (NYSE:BX) is reshaping its business with new leadership in private wealth to expand multi strategy solutions and international reach. The firm is increasing its presence in technology and industrials through fresh investments, including the acquisition of Advanced Cooling Technologies in thermal management. Blackstone has entered a partnership and AI joint venture discussions with Anthropic, tying its capital and portfolio closer to artificial intelligence infrastructure and...

Matson announced the upcoming retirement of Executive Vice President and Chief Commercial Officer John Lauer and named Chris Scott as his successor. The company outlined additional leadership promotions connected to this transition. Matson also launched a new cargo security initiative with BNSF Railway and War-Lok, adding multiple layers of protection for international intermodal cargo. Matson (NYSE:MATX) is pairing major leadership changes with an operational shift in how it protects...